Cargando…

Role of long non-coding RNA TP73-AS1 in cancer

Cancer incidence rate has increased so much that it is the second leading cause of deaths worldwide after cardiovascular diseases. Sensitive and specific biomarkers are needed for an early diagnosis of cancer and in-time treatment. Recent studies have found that long non-coding RNAs (lncRNAs) partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Caizhi, Shu, Long, Zou, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822500/
https://www.ncbi.nlm.nih.gov/pubmed/31652459
http://dx.doi.org/10.1042/BSR20192274
_version_ 1783464351442665472
author Chen, Caizhi
Shu, Long
Zou, Wen
author_facet Chen, Caizhi
Shu, Long
Zou, Wen
author_sort Chen, Caizhi
collection PubMed
description Cancer incidence rate has increased so much that it is the second leading cause of deaths worldwide after cardiovascular diseases. Sensitive and specific biomarkers are needed for an early diagnosis of cancer and in-time treatment. Recent studies have found that long non-coding RNAs (lncRNAs) participate in cancer tumorigenesis. LncRNA P73 antisense RNA 1T (TP73-AS1), also known as KIAA0495 and p53-dependent apoptosis modulator (PDAM), is located in human chromosomal band 1p36.32 and plays a crucial role in many different carcinomas. This review summarizes current findings on the role of TP73-AS1 and its signaling pathways in various cancers, including glioma, esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), colorectal cancer (CRC), osteosarcoma, gastric cancer (GC), clear cell renal cell carcinoma (ccRCC), breast cancer (BC), bladder cancer, ovarian cancer, cholangiocarcinoma (CCA), lung cancer, and pancreatic cancer. Its aberrant expression generally correlates with clinicopathological characterization of patients. Moreover, TP73-AS1 regulates proliferation, migration, invasion, apoptosis, and chemoresistance cancer mechanisms, both in vivo and in vitro, through different signaling pathways. Therefore, TP73-AS1 may be considered as a marker for diagnosis and prognosis, also as a target for cancer treatment.
format Online
Article
Text
id pubmed-6822500
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-68225002019-11-06 Role of long non-coding RNA TP73-AS1 in cancer Chen, Caizhi Shu, Long Zou, Wen Biosci Rep Cell Cycle, Growth & Proliferation Cancer incidence rate has increased so much that it is the second leading cause of deaths worldwide after cardiovascular diseases. Sensitive and specific biomarkers are needed for an early diagnosis of cancer and in-time treatment. Recent studies have found that long non-coding RNAs (lncRNAs) participate in cancer tumorigenesis. LncRNA P73 antisense RNA 1T (TP73-AS1), also known as KIAA0495 and p53-dependent apoptosis modulator (PDAM), is located in human chromosomal band 1p36.32 and plays a crucial role in many different carcinomas. This review summarizes current findings on the role of TP73-AS1 and its signaling pathways in various cancers, including glioma, esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), colorectal cancer (CRC), osteosarcoma, gastric cancer (GC), clear cell renal cell carcinoma (ccRCC), breast cancer (BC), bladder cancer, ovarian cancer, cholangiocarcinoma (CCA), lung cancer, and pancreatic cancer. Its aberrant expression generally correlates with clinicopathological characterization of patients. Moreover, TP73-AS1 regulates proliferation, migration, invasion, apoptosis, and chemoresistance cancer mechanisms, both in vivo and in vitro, through different signaling pathways. Therefore, TP73-AS1 may be considered as a marker for diagnosis and prognosis, also as a target for cancer treatment. Portland Press Ltd. 2019-10-18 /pmc/articles/PMC6822500/ /pubmed/31652459 http://dx.doi.org/10.1042/BSR20192274 Text en © 2019 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Cell Cycle, Growth & Proliferation
Chen, Caizhi
Shu, Long
Zou, Wen
Role of long non-coding RNA TP73-AS1 in cancer
title Role of long non-coding RNA TP73-AS1 in cancer
title_full Role of long non-coding RNA TP73-AS1 in cancer
title_fullStr Role of long non-coding RNA TP73-AS1 in cancer
title_full_unstemmed Role of long non-coding RNA TP73-AS1 in cancer
title_short Role of long non-coding RNA TP73-AS1 in cancer
title_sort role of long non-coding rna tp73-as1 in cancer
topic Cell Cycle, Growth & Proliferation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822500/
https://www.ncbi.nlm.nih.gov/pubmed/31652459
http://dx.doi.org/10.1042/BSR20192274
work_keys_str_mv AT chencaizhi roleoflongnoncodingrnatp73as1incancer
AT shulong roleoflongnoncodingrnatp73as1incancer
AT zouwen roleoflongnoncodingrnatp73as1incancer